Journal: Nature metabolism

Article Title: CD38 ecto-enzyme in immune cells is induced during aging regulating NAD + and NMN levels

doi: 10.1038/s42255-020-00298-z

Figure Lengend Snippet: Analysis of WAT ( a , b , f ) and liver ( c , d , e , g ) of young and old mice. ( a,c ) Representative immunofluorescence image for CD38 (red) and CD45 (green) in WAT and liver of young (3–4 month-old) and old (28–32 month-old) C57BL/6 mice (4 mice per group), compared to isotype control or CD38 Knockout (KO). ( b,d ) CD38 + , CD38 + CD45 − , and CD38 + CD45 + cells in young (4 month-old) and old (32 month-old) mice were determined by flow cytometry in WAT (CD38 + , CD38 + CD45 + n=9 mice per group; CD38 + CD45 − n=5 mice for young, 6 mice for old) and liver (young n=4 mice per group; old n=5 mice per group), changes are relative to young mice. ( e ) In the left panel, flow cytometry-derived color-coded cell clusters of CD38 + immune cell types in liver of young (4 month-old) and old (32 month-old) mice analyzed by Uniform Manifold Approximation and Projection (UMAP). In the right panel, heat maps show CD38 protein expression (lowest in blue and highest in red) in the respective immune clusters (n=4 for young and n=5 for old). ( f ) Graph shows CD45 + F4/80 + CD38 + cell population in WAT of young (4 month-old, n=5 mice) and old mice (32 month-old, n=6 mice). Fold changes are relative to young mice. ( g ) CD38 + CD45 + subsets increase with age in liver tissue (Classical monocytes, monocyte-derived macrophages, CD8 + T cells, and granulocytes n=6 mice; CD4 + T cells n=4 mice). Change is relative to young mice. ( h ) CD38 activity in mouse immune cells isolated from spleen (n=3 biologically independent samples). ( i-k ) Macrophages isolated from 3 month-old and 18 month-old mice were stimulated with different concentrations of LPS for 20 hours. ( i ) Cd38 mRNA expression measured by qRT-PCR analysis (n=4 biologically independent samples). ( j ) CD38 activity measured in protein lysates (RFU-relative fluorescent units) (n=5, except for 18 mo 50 ng/mL LPS where n=4 biologically independent samples). ( k ) Representative immunoblotting of three biologically independent samples from macrophages treated with different concentrations of LPS. Data are mean ± SEM, analyzed by unpaired two-sided t-test, except for CD38 + CD45 + in , where samples were analyzed by unpaired on-sided t-test.

Article Snippet: During the binding step antibody-loaded sensors are dipped into wells containing recombinant mouse FcγR IV (mouse FcγR IV -FC4-M52H3, Acro Biosystems), recombinant mouse FcγR I (mouse FcγR I -CD4M5227, Acro Biosystems), or recombinant mouse CD38 (mouse CD38– 50191-M08H, Sino Biological).

Techniques: Immunofluorescence, Control, Knock-Out, Flow Cytometry, Derivative Assay, Expressing, Activity Assay, Isolation, Quantitative RT-PCR, Western Blot

Journal: Nature metabolism

Article Title: CD38 ecto-enzyme in immune cells is induced during aging regulating NAD + and NMN levels

doi: 10.1038/s42255-020-00298-z

Figure Lengend Snippet: ( a ) Graphs show no change in CD38 + CD31 + cell population in WAT and liver tissues between young (4 month-old) and old (32 month-old) mice (n=3 for liver and n=9 mice for WAT). ( b ) Gating strategy used to show the CD45 + CD38 + population in WAT of young (4 month-old) and old (22 month-old) mice. ( c ) Histograms of CD38 + population in young (4 month-old) and old (22 month-old) WAT showing the shift in CD38 expression. The graph shows the relative area under the curve (AUC) for young and old (n=5 mice per group). ( d ) Histograms showing the CD38 expression in different immune cells in young (4 month-old) and old (32 month-old) liver. Table shows cell counts for each subset of immune cells, the data are representative of n=5 mice per group. ( e ) Gating strategy for CD45 + immune subsets in CD38 + liver cells in young (4 month-old) and old mice (32 month-old). Data are mean ± SEM, analyzed by unpaired two-sided t -test.

Article Snippet: During the binding step antibody-loaded sensors are dipped into wells containing recombinant mouse FcγR IV (mouse FcγR IV -FC4-M52H3, Acro Biosystems), recombinant mouse FcγR I (mouse FcγR I -CD4M5227, Acro Biosystems), or recombinant mouse CD38 (mouse CD38– 50191-M08H, Sino Biological).

Techniques: Expressing

Journal: Nature metabolism

Article Title: CD38 ecto-enzyme in immune cells is induced during aging regulating NAD + and NMN levels

doi: 10.1038/s42255-020-00298-z

Figure Lengend Snippet: ( a-g ) Sub-lethally irradiated 3 month-old CD38 KO mice were subjected to bone marrow transplant (BMT) with 1×10 6 bone marrow cells (BMC) per animal from either WT (WT>KO) or CD38 KO donors (KO>KO). Twelve weeks after transplantation, μice were subcutaneously injected with LPS (300 μg/kg) or vehicle daily for 5 days and harvested at day 5 (n=4 mice per group). Figure shows analyses in WAT. ( a ) Schematic of experiment. ( b ) Relative Cd38 mRNA expression measured by qRT-PCR. Expression is relative to WT>KO group. ND denotes non-detectable. ( c ) CD38 activity. ( d ) Representative immunoblotting showing CD38 levels in 3 mice from each treatment group. ( e ) mRNA expression of Cd45 and F4/80 measured by qRT-PCR. Expression is relative to CD38 KO (KO>KO). ( f ) Immunofluorescent staining of CD38 (red) and CD45 (green), representative of 4 mice per group. The graph shows quantification of CD38 and CD45 positive cells from the images (n=3 fields obtained from a representative mouse from each treatment group). ( g ) NAD + and NMN levels. Data are mean ± SEM, analyzed by unpaired two-sided t-test.

Article Snippet: During the binding step antibody-loaded sensors are dipped into wells containing recombinant mouse FcγR IV (mouse FcγR IV -FC4-M52H3, Acro Biosystems), recombinant mouse FcγR I (mouse FcγR I -CD4M5227, Acro Biosystems), or recombinant mouse CD38 (mouse CD38– 50191-M08H, Sino Biological).

Techniques: Irradiation, Transplantation Assay, Injection, Expressing, Quantitative RT-PCR, Activity Assay, Western Blot, Staining

Journal: Nature metabolism

Article Title: CD38 ecto-enzyme in immune cells is induced during aging regulating NAD + and NMN levels

doi: 10.1038/s42255-020-00298-z

Figure Lengend Snippet: ( a-b ) 12 month-old mice received daily subcutaneous injection of vehicle (Ctrl) or LPS (300 μg/kg) for 5 days (n=9 mice per group). ( a ) mRNA expression of Cd38 , F4/80 , and Cd45 in subcutaneous WAT (Subq WAT) measured by qRT-PCR analysis and expressed relative to Ctrl. ( b ) Immunofluorescent staining for CD38 (red) and CD45 (green) in Subq WAT, showing accumulation of CD38 + CD45 + cells with LPS treatment. Images are representative of 6 mice per group. ( c-h ) Sub-lethally irradiated CD38 KO mice were subjected to bone marrow transplant (BMT) with 1×10 6 bone marrow cells (BMC) per animal from either WT (WT>KO) or CD38 KO donors (KO>KO). Twelve weeks after transplantation, mice were subcutaneously injected with LPS (300 μg/kg) or vehicle daily for 5 days and harvested at day 5. ( c , d ) CD38 activity and NAD + levels in spleen and jejunum (n=4 mice per group). ( e ) CD38 expression by immunoblot (n=3 mice per group). ( f ) Number of CD38 + cells by flow cytometry was measured in spleen and jejunum with and without LPS treatment (n=5 mice per group). ( g , h ) CD38 activity and NAD + levels in liver and pancreas (n=4 mice per group). ( i ) CD38 activity was measured in macrophages isolated from WT or CD38 KO mice and treated or not with LPS (100 ng/mL) with and without the CD38 inhibitor 78c (0.5 μM) for 24 hours. CD38 activity is relative to Ctrl WT (n=3 biologically independent samples). ( j ) Macrophages isolated from WT or CD38 KO mice were treated or not with LPS (100 ng/mL) for 24 hours and mRNA expression of Cd38 and other markers of macrophage activation were measured. Expression was measured by qRT-PCR analysis and expressed relative to Ctrl WT (n=4 biologically independent samples). Data are mean ± SEM, analyzed by unpaired two-sided t -test, NS=non-significant.

Article Snippet: During the binding step antibody-loaded sensors are dipped into wells containing recombinant mouse FcγR IV (mouse FcγR IV -FC4-M52H3, Acro Biosystems), recombinant mouse FcγR I (mouse FcγR I -CD4M5227, Acro Biosystems), or recombinant mouse CD38 (mouse CD38– 50191-M08H, Sino Biological).

Techniques: Injection, Expressing, Quantitative RT-PCR, Staining, Irradiation, Transplantation Assay, Activity Assay, Western Blot, Flow Cytometry, Isolation, Activation Assay

Journal: Nature metabolism

Article Title: CD38 ecto-enzyme in immune cells is induced during aging regulating NAD + and NMN levels

doi: 10.1038/s42255-020-00298-z

Figure Lengend Snippet: ( a-b ) Immunofluorescent staining of WAT from young (2 month-old) and old (28 month-old) C57BL/6 mice. ( a ) Images of WAT stained with CD38 (red), lamin B1 (green), and ORF1 (yellow), representative of 3 mice per group. Insets show an enlarged portion of old tissue, with and without ORF1 signal, to highlight that CD38 + cells are present near ORF1 + lamin B1 − cells. ( b ) Images of WAT stained with CD38 (red), CD45 (green), and ORF1 (yellow), representative of 6 mice per group. Insets show the image of old WAT with removal of green color channel CD45 signal (left) and with removal of red color channel CD38 signal (right) to show accumulation of CD38 + CD45 + cells near ORF1 + cells. ( c-e ) 12 month-old INK-ATTAC mice were treated with vehicle or AP20187 for 16 months. At 28 months these mice were euthanized and compared with 12 month-old INK-ATTAC mice. Analyses were performed in WAT. ( c ) Schematic of experiment. ( d ) p16 and Cd38 mRNA levels detected by qRT-PCR analysis (12 mo n=5 mice; 28 mo n=6 mice; 28 mo+AP n=12 mice) ( e ) NAD + levels (12 mo n=5 mice; 28 mo n=6 mice; 28 mo+AP n=14 mice). ( f - g ) 18 month-old WT C57BL/6 mice were injected IP with DiI-labelled (yellow) senescent (SEN) or non-senescent (NS) mouse pre-adipocytes (mPA) from WT mice. ( f ) Schematic of experiment. ( g ) Immunofluorescent staining of CD38 (red) and CD45 (green) in WAT (representative of n=4 mice per group). Accumulation of CD38 + CD45 + cells was increased when senescent cells were injected. ( h-j ) 12 month-old CD38 KO mice were injected IP with vehicle, senescent (SEN), or non-senescent (NS) mPA from WT mice. 48 hours later, mice were injected with luciferase labeled PBMCs. Control mice received PBMCs only. ( h ) Schematic of experiment. ( i ) Representative images showing increase in luciferase + PBMCs in mice injected with SEN mPA. ( j ) Relative Cd38 mRNA levels measured by qRT-PCR in WAT (Ctrl and SEN mPA n=7 mice; NS mPA n=8 mice). Data are mean ± SD ( d,e ) and SEM ( j ), analyzed by unpaired two-sided t-test.

Article Snippet: During the binding step antibody-loaded sensors are dipped into wells containing recombinant mouse FcγR IV (mouse FcγR IV -FC4-M52H3, Acro Biosystems), recombinant mouse FcγR I (mouse FcγR I -CD4M5227, Acro Biosystems), or recombinant mouse CD38 (mouse CD38– 50191-M08H, Sino Biological).

Techniques: Staining, Quantitative RT-PCR, Injection, Luciferase, Labeling, Control

Journal: Nature metabolism

Article Title: CD38 ecto-enzyme in immune cells is induced during aging regulating NAD + and NMN levels

doi: 10.1038/s42255-020-00298-z

Figure Lengend Snippet: ( a ) WT macrophages were incubated with LPS (100 ng/mL) in the presence or absence of 100 nM AP20187 for 20 hours. CD38 activity was measured in cell lysates (n=4 biologically independent samples). ( b ) WT macrophages were treated with LPS (100 ng/mL) for 20 hours and cell lysates were prepared. Lysates were incubated with or without AP20187 for 15 min before CD38 activity was measured (n=3 biologically independent samples). ( c - g ) 12 month-old INK-ATTAC mice were treated with vehicle or with AP20187 for 16 months (28 month-old groups) and were compared with 12 month-old animals. ( c ) Representative images of immunofluorescent staining for CD38 (red), ORF1 (yellow), and CD45 (green) in WAT. Insets show the image of 28 month-old WAT with removal of green color channel CD45 signal (left) and with removal of red color channel CD38 signal (right) to show accumulation of CD38 + CD45 + cells near ORF1 + cells. Graph shows quantification of CD45 + immune clusters in WAT, based on 20 5x fields per sample (12 mo, n=5; 28 mo, n=4; 28 mo+AP, n=3 mice). ( d ) IL6 levels in WAT detected by ELISA (12 mo n=5; 28 mo n=7; 28 mo+AP n=6 mice). ( e ) NMN levels measured in WAT (12 mo n=5; 28 mo n=6; 28 mo+AP n=13 mice). ( f ) Relative mRNA levels of p16 (12 mo n=6; 28 mo n=7; 28 mo+AP n=5 mice) and Cd38 (12 mo n=10; 28 mo n=9; 28 mo+AP n=6 mice) detected by qRT-PCR analysis in liver. Levels are relative to 12 month-old mice. ( g ) NAD + levels in liver (12 mo n=6; 28 mo n=7; 28 mo+AP n=15 mice). ( h ) Relative mRNA levels of inflammatory and senescence-related genes in X-ray irradiated WT mouse pre-adipocytes determined by qRT-PCR. Levels are relative to control non-senescent cells (Ctrl) (Ctrl n=5; X-ray n=6 biologically independent samples). ( i ) Quantitative analysis of cytokines/chemokines in conditioned media harvested from irradiated (CM-SEN) or non-senescent (CM-NS) mouse pre-adipocytes. Heat maps reflect analytes (pg/mL) measured in 3–25-plex Luminex assays. Heat map shows average of 5 biologically independent samples. Data are mean ± SEM, except letters e-g that are mean ± SD, analyzed by unpaired two-sided t -test.

Article Snippet: During the binding step antibody-loaded sensors are dipped into wells containing recombinant mouse FcγR IV (mouse FcγR IV -FC4-M52H3, Acro Biosystems), recombinant mouse FcγR I (mouse FcγR I -CD4M5227, Acro Biosystems), or recombinant mouse CD38 (mouse CD38– 50191-M08H, Sino Biological).

Techniques: Incubation, Activity Assay, Staining, Enzyme-linked Immunosorbent Assay, Quantitative RT-PCR, Irradiation, Control, Luminex

Journal: Nature metabolism

Article Title: CD38 ecto-enzyme in immune cells is induced during aging regulating NAD + and NMN levels

doi: 10.1038/s42255-020-00298-z

Figure Lengend Snippet: ( a - b ) WT macrophages were incubated with conditioned media from senescent (CM-SEN) and non-senescent (CM-NS) mouse pre-adipocytes for 20 hours. CD38 expression and activity are relative to CM-NS. ( a ) Cd38 mRNA expression in the macrophages was measured by qRT-PCR analysis. (n=5 biologically independent samples). ( b ) Relative CD38 activity in macrophage lysates (n=5 biologically independent samples). ( c ) WT macrophages were treated with LPS (100 ng/mL) with and without 3TC (10 μM) for 20 hours and CD38 activity was measured in cell lysates (n=3 biologically independent samples). ( d ) WT macrophages were incubated with conditioned media from senescent (CM-SEN) and non-senescent (CM-NS) mouse pre-adipocytes for 20 hours. Conditioned media was pre-incubated for 2 hours with or without IL6 or TNF-α antibody (5 μg/mL) before addition to the macrophages. CD38 activity was measured in cell lysates, and expressed relative to CM-NS (CM-NS and CM-SEN n=8; CM-NS+IL6 Ab and CM-SEN+IL6 n=6; CM-NS+TNF Ab and CM-SEN+TNF n=4 biologically independent samples). ( e ) HUVECs were treated with conditioned media from senescent (CM-SEN) and non-senescent (CM-NS) mouse embryonic fibroblasts for 20 hours. CM was pre-incubated for 2 hours with or without TNF-α antibody (5 μg/mL) before addition to the HUVECs. Cd38 mRNA expression was measured by qRT-PCR analysis (CM-NS n=12; CM-NS+TNF Ab n=4; CM-SEN n=10; CM-SEN+TNF Ab n=4 biologically independent samples). Data are mean ± SEM, analyzed by unpaired two-sided t -test.

Article Snippet: During the binding step antibody-loaded sensors are dipped into wells containing recombinant mouse FcγR IV (mouse FcγR IV -FC4-M52H3, Acro Biosystems), recombinant mouse FcγR I (mouse FcγR I -CD4M5227, Acro Biosystems), or recombinant mouse CD38 (mouse CD38– 50191-M08H, Sino Biological).

Techniques: Incubation, Expressing, Activity Assay, Quantitative RT-PCR

Journal: Nature metabolism

Article Title: CD38 ecto-enzyme in immune cells is induced during aging regulating NAD + and NMN levels

doi: 10.1038/s42255-020-00298-z

Figure Lengend Snippet: ( a - b )12 month-old WT mice received daily subcutaneous injection of conditioned media from senescent (CM-SEN) or non-senescent (CM-NS) mouse pre-adipocytes for 5 days, and were harvested at day 5. ( a ) CD38 activity (n=7 mice per group) and NAD + levels (CM-NS n=7 mice; CM-SEN n=6 mice) were measured in subcutaneous WAT (Subq WAT). ( b ) Relative Cd38 (n=11 mice per group), Cd45, and F4/80 (CM-NS n=14 mice; CM-SEN n=12 mice) mRNA expression measured by qRT-PCR in Subq WAT. Levels were relative to CM-NS. ( c-f ) 26 month-old mice were treated with vehicle (Ctrl) or 3TC for 2 weeks. ( c ) Schematic of experiment. ( d ) Relative mRNA levels for p16 and SASP components measured by qRT-PCR in WAT (n=8 mice per group for all conditions except Pai1 3TC where n=7 mice). ( e ) Relative mRNA levels for F4/80 (n=8 mice per group), Cd38, Parp1, and Sirt1 (n=5 mice per group) measured by qRT-PCR in WAT. ( f ) Relative NAD + levels in WAT (n=5 mice per group). Levels were relative to vehicle-treated mice. ( g ) Immunofluorescent staining of CD38 (red), lamin B1 (green), and IL6 (yellow) in WAT of young (2 month-old) and old (28 month-old) C57BL/6 mice, representative of 4 young and 6 old mice. Insets show enlarged area of old tissue with and without IL6 staining, to highlight that CD38 can be found near IL6 + lamin B1 − cells. Data are mean ± SEM, analyzed by unpaired two-sided t -test. Two statistical outliers were identified in the Cd45 mRNA expression of the CM-SEN-treated animals (with values higher than 16) using the appropriate test in GraphPad Prism 6. These samples were excluded from all the PCR analyses for this experiment. Data were also analyzed by non-parametric Mann-Whitney using the full data set (including the identified statistical outliers) and the p value for Cd45 was 0.002.

Article Snippet: During the binding step antibody-loaded sensors are dipped into wells containing recombinant mouse FcγR IV (mouse FcγR IV -FC4-M52H3, Acro Biosystems), recombinant mouse FcγR I (mouse FcγR I -CD4M5227, Acro Biosystems), or recombinant mouse CD38 (mouse CD38– 50191-M08H, Sino Biological).

Techniques: Injection, Activity Assay, Expressing, Quantitative RT-PCR, Staining, MANN-WHITNEY

Journal: Nature metabolism

Article Title: CD38 ecto-enzyme in immune cells is induced during aging regulating NAD + and NMN levels

doi: 10.1038/s42255-020-00298-z

Figure Lengend Snippet: ( a-f ) 12 month-old WT and transgenic catalytically inactive CD38 (CI) mice were treated with vehicle (Ctrl) or a single dose of doxorubicin (Doxo, 15 mg/kg), and WAT was harvested 10 days later for analyses (CI n=4 mice; WT, WT+Doxo, CI+Doxo n=5 mice per group). ( a ) Schematic of experiment. ( b ) p21, II6, Il1b , and F4/80 mRNA expression measured by qRT-PCR. ( c ) Cd38 mRNA expression measured by qRT-PCR. ( d ) Representative immunoblotting of CD38 protein levels and graph showing quantification of CD38 levels. The quantification is a ratio of CD38/tubulin levels (n=3 mice per group). ( e ) CD38 activity. ( f ) NAD + levels. Data are mean ± SEM, analyzed by unpaired two-sided t-test.

Article Snippet: During the binding step antibody-loaded sensors are dipped into wells containing recombinant mouse FcγR IV (mouse FcγR IV -FC4-M52H3, Acro Biosystems), recombinant mouse FcγR I (mouse FcγR I -CD4M5227, Acro Biosystems), or recombinant mouse CD38 (mouse CD38– 50191-M08H, Sino Biological).

Techniques: Transgenic Assay, Expressing, Quantitative RT-PCR, Western Blot, Activity Assay

Journal: Nature metabolism

Article Title: CD38 ecto-enzyme in immune cells is induced during aging regulating NAD + and NMN levels

doi: 10.1038/s42255-020-00298-z

Figure Lengend Snippet: ( a-c ) 293T cells were transfected with vector (V), CD38 WT, CD38 catalytically-inactive (CI), or CD38 Δ49 expression plasmid. ( a ) Representative immunoblotting (of four biologically independent samples) showing CD38 expression in whole cell lysates of 293T cells transfected with CD38 plasmids. ( b ) Immunofluorescence of fixed 293T cells transfected with CD38 plasmids (n=3 biologically independent samples). Cells were labeled with CD38 antibody and a membrane dye, followed by Hoechst staining. Yellow arrows indicate membrane CD38, white arrows show intracellular CD38. ( c ) NAD + levels in transfected 293T cells (V, WT, Δ49 n=6; CI n=4 biologically independent samples). ( d - e ) 293T cells were transfected with vector, CD38 WT, or CD38 Δ49 and 20 hours later were incubated with isatuximab (isa, 5 μg/mL) or 78c (0.5 μM). When NMN was added, it was 4 hours after drugs. NAD + levels were measured 20 hours after drug treatments (n=5 biologically independent samples). Levels are relative to vector-transfected cells. ( f ) NAD + levels in AML12 cells co-cultured with 293T cells expressing CD38 plasmids. 293T cells were treated with and without 200 μM NMN 20 hours after transfection. AML 12 cells were collected 20 hours after addition of NMN (n=5 biologically independent samples). Levels are relative to vector-transfected cells. Data are mean ± SEM, analyzed by unpaired two-sided t -test, NS=non-significant.

Article Snippet: During the binding step antibody-loaded sensors are dipped into wells containing recombinant mouse FcγR IV (mouse FcγR IV -FC4-M52H3, Acro Biosystems), recombinant mouse FcγR I (mouse FcγR I -CD4M5227, Acro Biosystems), or recombinant mouse CD38 (mouse CD38– 50191-M08H, Sino Biological).

Techniques: Transfection, Plasmid Preparation, Expressing, Western Blot, Immunofluorescence, Labeling, Membrane, Staining, Incubation, Cell Culture

Journal: Nature metabolism

Article Title: CD38 ecto-enzyme in immune cells is induced during aging regulating NAD + and NMN levels

doi: 10.1038/s42255-020-00298-z

Figure Lengend Snippet: ( a ) 293T cells were transfected with vector (V), CD38 WT (WT), CD38 CI (CI) or CD38 Δ49 (Δ49). Representative immunoblotting of 4 independent experiments showing CD38 expression in cytosol of 293T cells transfected with CD38 plasmids. ( b ) Immunofluorescence of fixed 293T cells transfected with CD38 plasmids. Images are representative of 3 independent experiments. Cells were labeled with CD38 antibody and a membrane dye, followed by Hoechst staining. Images show separate CD38 and membrane staining. ( c - d ) Lysates of transfected 293T cells were incubated with varied concentrations of the human CD38 antibody isatuximab (isa) or 0.5 μM 78c for 15 min before CD38 activity was measured. Activity is relative to control (no antibody). ( c ) Lysates of 293T transfected with CD38 WT plasmid (n=4 biologically independent samples). ( d ) Lysates of 293T transfected with CD38 Δ49 plasmid (n=3 biologically independent samples). ( e ) Human recombinant CD38 (hCD38) (100 ng/mL) was incubated with and without isatuximab (5 μg/mL) for 2 hours and then added to 293T cells together with NMN (300 μM). Control samples had no CD38 and no NMN. 293T were incubated with NMN and hCD38 for 20 hours and NAD + levels were measured in the 293T cells. Values show the difference from untreated control (n=3 except for NMN+hCD38+isa where n=4 biologically independent samples). ( f ) Scheme representing the coculture model. ( g ) NAD + levels in AML 12 cells co-cultured with 293T cells expressing vector or CD38 WT. 293T cells were treated with and without 200 μM NMN 20 hours after transfection in the presence or absence of 5 μg/ml isatuximab. AML 12 cells were collected 20 hours after incubation with 293T cells (n=3 except for V+NMN where n=4 biologically independent samples). Levels are relative to vector-transfected cells. Data are mean ± SEM, analyzed by unpaired two-sided t -test.

Article Snippet: During the binding step antibody-loaded sensors are dipped into wells containing recombinant mouse FcγR IV (mouse FcγR IV -FC4-M52H3, Acro Biosystems), recombinant mouse FcγR I (mouse FcγR I -CD4M5227, Acro Biosystems), or recombinant mouse CD38 (mouse CD38– 50191-M08H, Sino Biological).

Techniques: Transfection, Plasmid Preparation, Western Blot, Expressing, Immunofluorescence, Labeling, Membrane, Staining, Incubation, Activity Assay, Control, Recombinant, Cell Culture

Journal: Nature metabolism

Article Title: CD38 ecto-enzyme in immune cells is induced during aging regulating NAD + and NMN levels

doi: 10.1038/s42255-020-00298-z

Figure Lengend Snippet: ( a-b ) NAD + levels in BMDM from 3 month-old WT ( a ) and CD38 KO ( b ) mice. Macrophages were treated with vehicle (Ctrl) or LPS (100 ng/mL), with or without 78c (0.5 μM) (n=7; with exception of WT LPS+78c where n=6 biologically independent samples). ( c-k ) BMDM isolated from 18 month-old WT mice. ( c ) NAD + levels in macrophages treated with LPS (100 ng/mL), Ab68 (5 μg/mL), 78c (0.5 μM), and olaparib (olap, 5 μM) (Ctrl, LPS n=11; LPS+78c n=4; LPS+78c, LPS+olap, LPS+78c+olap n=9 biologically independent samples). ( d ) Macrophages were treated with LPS (100 ng/mL), Ab68 (5 μg/mL), 78c (0.5 μM), and olaparib (olap, 5 μM). 3 hours later, 300 μM NMN was added and cells were collected 20 hours later for NAD + measurements (n=7 except for NMN+LPS+olap and NMN+LPS+olap+78c where n=6 biologically independent samples). ( e ) Representative immunoblotting of three biologically independent samples of M0 or M1 (LPS-treated) macrophages and AML12 lysates showing CD38 and Slc12a8. ( f ) NAD + levels in AML 12 cells cocultured with macrophages. Macrophages were treated with LPS (100 ng/mL), Ab68 (10 μg/mL), and NMN (200 μM) before incubation with AML 12 cells (n=7 biologically independent samples except for LPS+Ab68 where n=5). ( g ) Extracellular NMN in culture media after treatment of macrophages with 100 μM NMN, LPS (100 ng/mL), and Ab68 (5 μg/mL). LPS was given 9 hours before NMN, and Ab68 was given 3 hours before NMN. Cells were incubated with NMN for 12 hours before media was collected (n=5 biologically independent samples). ( h ) NAD + levels in AML 12 cells cocultured with macrophages. Macrophages were treated with LPS (100 ng/mL), Ab68 (10 μg/mL), and NR (200 μM) before incubation with AML 12 cells (n=5 biologically independent samples). ( i ) NAD + levels in macrophages treated with CM from non-senescent (CM-NS) or senescent mouse pre-adipocytes (CM-SEN or CM-SEN + 78c (0.5 μM)) (n=6 biologically independent samples). ( j-k ) NAD + (n=8 biologically independent samples except for CM SEN+NMN+Ab68 where n=7) and NMN levels (n=4 biologically independent samples) in AML 12 cells cocultured with macrophages. Macrophages were treated with CM-NS or CM-SEN from mouse preadipocytes, Ab68 (10 μg/mL), and NMN (200 μM) before incubation with AML 12 cells. All levels are relative to their respective control (Ctrl or CM-NS). Data are mean ± SEM, analyzed by unpaired two-sided t-test.

Article Snippet: During the binding step antibody-loaded sensors are dipped into wells containing recombinant mouse FcγR IV (mouse FcγR IV -FC4-M52H3, Acro Biosystems), recombinant mouse FcγR I (mouse FcγR I -CD4M5227, Acro Biosystems), or recombinant mouse CD38 (mouse CD38– 50191-M08H, Sino Biological).

Techniques: Isolation, Western Blot, Incubation, Control

Journal: Nature metabolism

Article Title: CD38 ecto-enzyme in immune cells is induced during aging regulating NAD + and NMN levels

doi: 10.1038/s42255-020-00298-z

Figure Lengend Snippet: ( a ) Relative mRNA expression of Nampt and Cd157 after treatment of BMDMs of WT and CD38 KO mice with and without 100 ng/mL LPS for 24 hours. Expression, assessed by qRT-PCR, is relative to Ctrl WT (n=4 biologically independent samples). ( b-g ) Characterization of the mouse anti-CD38 antibodies used in this study. ( b ) Schematic representation of a human heavy chain-only antibody (UniAbs). ( c ) Workflow to discover CD38-specific UniAbs. Antibodies were derived from transgenic rats, called UniRats that produce heavy-chain antibodies with fully human V H domains (UniAbs) in response to an antigen challenge. ( d ) Development of UniRat transgenic animals. ( e ) Protein and cell-based screens to discover anti-CD38 UniAbs. ( f ) Graph showing the binding of FITC-labeled Ab68 to freshly isolated mouse spleen cells (n=3 biologically independent samples). ( g ) Effect of Ab68 on the rate of CD38 hydrolase activity at different concentrations of substrate (left, n=8; except for no e-NAD where n=4 biologically independent samples and respective Lineweaver-Burk plots (right, n=6 biologically independent samples). ( h ) Table shows the binding affinities (KD) of anti-mouse CD38 antibodies Ab68 and Ab69 and a mouse control antibody OKT3. NB=No Binding. ( i ) Apoptosis of CHO cells stably transfected with mouse CD38 after incubation with antibodies Ab68, Ab69, and NIMR-5 for 24 hours (n=2 samples per concentration). ( j ) Cell viability of WT macrophages treated with LPS (100 ng/mL), with or without Ab68 or Ab69 (5 μg/mL) for 24 hours (n=4 except for LPS+Ab69 where n=3 biologically independent samples). ( k ) Graph shows the internalization of Ab68 compared to control antibody NIMR-5 after 45 minutes and 1.5 hours. ( l ) NAD + levels in AML 12 treated with 200 μM NMN in the presence or absence of LPS (100 ng/mL), Ab68 (5 μg/mL), and 78c (0.5 μM). LPS was given for 18 hours, then Ab68 was added, and 3 hours later NMN was added. Cells were collected 20 hours after NMN was added. NAD + levels were relative to control (Ctrl) (n=4 biologically independent samples). ( m ) NAD + levels in AML 12 cells cocultured with macrophages from CD38 KO mice. LPS was given for 18 hours to the macrophages, then NMN or NR (200 μM) were added for 3 hours. Next, macrophages were incubated with AMLs, and AML cells were collected 20 hours later. NAD + levels were relative to control (Ctrl) (n=4 biologically independent samples). ( n ) NAD + levels in AML 12 cocultured with macrophages. Macrophages were treated with 200 μM NA in the presence or absence of LPS (100 ng/mL), and Ab68 (5 μg/mL). LPS was given for 18 hours, then Ab68 was added, and 3 hours later nicotinic acid (NA) was added to the macrophages. Three hours after addition of NA, macrophages were incubated with AML cells. AML cells were collected 20 hours later and NAD + levels were calculated relative to control (Ctrl) (n=5 biologically independent samples). ( o ) Macrophages were incubated with conditioned media from senescent (CM-SEN) and non-senescent (CM-NS) mouse pre-adipocytes, and with LPS and without (Ctrl) for 20 hours. Cd38 mRNA expression (CM-NS and CM-SEN n=5; Ctrl and LPS n=4 biologically independent samples), CD38 activity (n=5 biologically independent samples), and NAD + levels (n=6 biologically independent samples) were measured in the macrophages. Samples from cells incubated with CM-SEN, were calculated relative to cells incubated with CM-NS. Samples from cells treated with LPS, were calculated relative to vehicle-treated cells (Ctrl). Data are mean ± SEM, analyzed by unpaired two-sided t -test, NS= non-significant.

Article Snippet: During the binding step antibody-loaded sensors are dipped into wells containing recombinant mouse FcγR IV (mouse FcγR IV -FC4-M52H3, Acro Biosystems), recombinant mouse FcγR I (mouse FcγR I -CD4M5227, Acro Biosystems), or recombinant mouse CD38 (mouse CD38– 50191-M08H, Sino Biological).

Techniques: Expressing, Quantitative RT-PCR, Derivative Assay, Transgenic Assay, Binding Assay, Labeling, Isolation, Activity Assay, Control, Stable Transfection, Transfection, Incubation, Concentration Assay

Journal: Nature metabolism

Article Title: CD38 ecto-enzyme in immune cells is induced during aging regulating NAD + and NMN levels

doi: 10.1038/s42255-020-00298-z

Figure Lengend Snippet: ( a-c ) 4 month-old WT and CD38 KO mice were treated with vehicle (Ctrl), Ab68 (5 mg/kg), or Ab69 (5 mg/kg) by intraperitoneal (i.p.) injection on day 1 and day 5, and euthanized on day 8. ( a ) Relative CD38 activity in WAT. Levels are relative to control WT (Ctrl) (WT Ctrl n=6; WT Ab68, CD38 KO n=5; WT Ab69 n=3 mice). ( b ) NAD + levels in WAT (WT n=4 mice; CD38 KO n=5 mice). ( c ) Heat map showing levels of metabolites in WT mice treated with Ab68 and Ab69 relative to Ctrl (n=4 mice per group). ( d ) 4 month-old WT mice were treated withFK866 (FK) (25 mg/kg) and/or Ab68 (5 mg/kg) (n=5 mice per group). NMN and NAD + levels were measured in WAT. Levels are relative to Ctrl. ( e ) 22 month-old WT mice were injected i.p. with a single dose of vehicle (Ctrl) or Ab68 (5 mg/kg), euthanized at different time points, and NMN and NAD + levels measured in WAT. Graphs show the time course of the relative increase of NMN or NAD + in vehicle and Ab68-treated over levels at time 0 (n=4 mice per group). ( f ) 18 month-old mice were injected i.p. with a single dose of vehicle (Ctrl) or Ab68 (5 mg/kg) and mice were euthanized at different time points. NMN levels were measured in serum (Ctrl, 0, 24, 72 hours, and Ab68 72 hours n=4 mice per group; Ab68 24 hours n=5 mice; Ctrl 6 hours n=8 mice; Ab68 6 hours n=9 mice). ( g ) 18 month-old WT mice were injected i.p. with vehicle (Ctrl, NMN groups), 5 mg/kg Ab68 (Ab68, Ab68+NMN groups), with and without 500 mg/kg NMN. Serum NMN levels were determined (n=5 mice per group). ( h ) Absolute NAD + levels in WAT of 3 month-old (young) and 18 month-old (old) mice were determined 3 days after treatment with a single injection i.p. injection of vehicle (Ctrl) or 5 mg/kg Ab68 (n=5 mice per group). ( i ) 3 month old and 18 month-old mice were treated with Ab68 and NMN as described in panel ( g ) and WAT levels of NAD + were measured. NAD + levels after each treatment are expressed relative to its age-matched control (vehicle treatment) (n=5 mice per group). Data are mean ± SEM, analyzed by unpaired two-sided t -test, except for (e-f) where data are analyzed by two-way ANOVA.

Article Snippet: During the binding step antibody-loaded sensors are dipped into wells containing recombinant mouse FcγR IV (mouse FcγR IV -FC4-M52H3, Acro Biosystems), recombinant mouse FcγR I (mouse FcγR I -CD4M5227, Acro Biosystems), or recombinant mouse CD38 (mouse CD38– 50191-M08H, Sino Biological).

Techniques: Injection, Activity Assay, Control

Journal: Nature metabolism

Article Title: CD38 ecto-enzyme in immune cells is induced during aging regulating NAD + and NMN levels

doi: 10.1038/s42255-020-00298-z

Figure Lengend Snippet: ( a - b ) 4 month-old WT and CD38 KO mice were treated with vehicle (Ctrl), Ab68 (5 mg/kg), or Ab69 (5 mg/kg) on day 1 and day 5, and euthanized on day 8. ( a ) CD38 activity in several tissues (liver n=5 except for Ctrl CD38 KO where n=4 mice; skeletal muscle n=3 except for Ab68 where n=2 mice; jejunum and spleen n=5 mice per group). ( b ) NAD + levels in several tissues (liver and spleen n=5 mice except for Ctrl CD38 KO where n=4; skeletal muscle and spleen n=5 mice per group). ( c ) 4 month-old WT mice were treated with a single injection of vehicle (Ctrl) or Ab68 (5 mg/kg). After 3 days, tissues were harvested and gene expression was measured in WAT by qRT-PCR. Values are relative to Ctrl (Ctrl n=5 mice; Ab68 n=4 mice). ( d ) 4 month-old WT mice were treated with vehicle (Ctrl) or Ab68 (5 mg/kg) on day 1 and day 5, and euthanized on day 8. NMN and nicotinamide (NAM) levels were measured in liver and skeletal muscle. Levels are relative to Ctrl (n=5 mice per group). ( e ) Relative NMN levels in WAT, liver and skeletal muscle of 4 month-old WT and CD38 KO mice. Levels are relative to WT mice (n=5 mice per group except for liver CD38 KO where n=3 mice and skeletal muscle CD38 KO where n=4 mice). ( f ) 22 month-old WT mice were injected with a single dose of vehicle (Ctrl) or Ab68 (5 mg/kg). Mice were euthanized at different time points, and NMN and NAD + levels were measured in liver. Graphs show the time course of the relative increase of NMN or NAD + in vehicle and Ab68-treated over levels at time 0 (n=4 mice per group). ( g ) Graph shows the difference between NMNase activity of CD38 in the blood of WT and CD38 KO mice (n=3 mice per group). ( h ) Human recombinant CD38 enzyme was incubated with NMN at different pHs, and levels of nicotinamide were measured by an enzymatic coupled reaction (n=3 biologically independent samples). ( i ) Relative levels of NAD + and NR in the serum of mice injected with a single injection of vehicle (Ctrl) or Ab68 (5 mg/kg). Mice were euthanized 3 days later and NAD + and NR levels in the serum were measured (n=6 mice per group). (j) Relative mRNA expression of inflammatory and SASP markers in WAT of 3 month-old (young) and 18 month-old mice (old) treated or not with a single injection of vehicle (Ctrl) or 5 mg/kg Ab68. WAT was collected 3 days after injection of Ab68 (n=5 except for Ctrl old where n=4). Data are mean ± SEM, analyzed by unpaired two-sided t -test, except for (f-g) where data are analyzed by two-way ANOVA.

Article Snippet: During the binding step antibody-loaded sensors are dipped into wells containing recombinant mouse FcγR IV (mouse FcγR IV -FC4-M52H3, Acro Biosystems), recombinant mouse FcγR I (mouse FcγR I -CD4M5227, Acro Biosystems), or recombinant mouse CD38 (mouse CD38– 50191-M08H, Sino Biological).

Techniques: Activity Assay, Injection, Expressing, Quantitative RT-PCR, Recombinant, Incubation

Journal: Nature metabolism

Article Title: CD38 ecto-enzyme in immune cells is induced during aging regulating NAD + and NMN levels

doi: 10.1038/s42255-020-00298-z

Figure Lengend Snippet: In young mice, levels of CD38 + inflammatory cells and senescent cells in tissues are lower than older mice. During aging there is an increase in senescent cells that, at least in part, through their senescence associated secretory phenotype (SASP), promotes accumulation of CD38 + immune cells. The ecto-enzymatic activity of CD38 in immune cells degrades NMN extracellularly, preventing the NMN-induced NAD + boosting in other cells in the tissue.

Article Snippet: During the binding step antibody-loaded sensors are dipped into wells containing recombinant mouse FcγR IV (mouse FcγR IV -FC4-M52H3, Acro Biosystems), recombinant mouse FcγR I (mouse FcγR I -CD4M5227, Acro Biosystems), or recombinant mouse CD38 (mouse CD38– 50191-M08H, Sino Biological).

Techniques: Activity Assay

Journal: Advanced Science

Article Title: CD38‐Specific Gallium‐68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET

doi: 10.1002/advs.202308617

Figure Lengend Snippet: Structure and in vitro characterization of AJ206. A) Structure of bicyclic peptide AJ206 having NOTA as bifunctional chelator for 68 Ga‐labeling B) Surface plasmon resonance (SPR) analysis showing affinity of AJ206 for CD38 using recombinant human CD38 protein; data is represented as mean ± SEM ( n = 2).

Article Snippet: The ligands used were His‐Tagged human CD38 (R&D systems, catalog # 2404‐AC, 43 kDa, 0.5 mg mL −1 stock concentration) and mouse CD38 proteins (R&D systems, catalog # 4947‐AC, 40 kDa, 1.81 mg mL −1 stock concentration), which were immobilized onto the CM5 chip.

Techniques: In Vitro, Labeling, SPR Assay, Recombinant

Journal: Advanced Science

Article Title: CD38‐Specific Gallium‐68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET

doi: 10.1002/advs.202308617

Figure Lengend Snippet: In vitro specificity of [ 68 Ga]Ga‐AJ206 for CD38. A) [ 68 Ga]Ga‐AJ206 binding (percent incubated activity, %IA) to different MM cells. Cells were incubated with 1 µCi [ 68 Ga]Ga‐AJ206 at 4 °C for 1 h. [ 68 Ga]Ga‐AJ206 uptake is CD38 expression dependent, and co‐incubation with 2 × 10 −6 m of nonradioactive AJ206 (blocking dose) significantly reduced radiotracer uptake confirming CD38 specificity. B) Flow cytometry analysis of CD38 surface expression in MM cells. C) CD38 receptor density in MM cells measured by quantibrite assay. D) Representative western blot of total CD38 protein expression (bottom panel). Densiometric analysis of western blot preformed using ImageJ software and band intensities represented as a ratio of CD38 protein to GAPDH control (top panel). E) Correlation of [ 68 Ga]Ga‐AJ206 uptake with surface CD38 receptor density; data in panels A, C, and E are represented as mean ± SD ( n = 3‐4). ns, P ≥ 0.05; ****, P ≤ 0.0001 is by unpaired Student's t test. Simple linear regression and Pearson coefficient were used in E.

Article Snippet: The ligands used were His‐Tagged human CD38 (R&D systems, catalog # 2404‐AC, 43 kDa, 0.5 mg mL −1 stock concentration) and mouse CD38 proteins (R&D systems, catalog # 4947‐AC, 40 kDa, 1.81 mg mL −1 stock concentration), which were immobilized onto the CM5 chip.

Techniques: In Vitro, Binding Assay, Incubation, Activity Assay, Expressing, Blocking Assay, Flow Cytometry, Western Blot, Software, Control

Journal: Advanced Science

Article Title: CD38‐Specific Gallium‐68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET

doi: 10.1002/advs.202308617

Figure Lengend Snippet: In vivo specificity of [ 68 Ga]Ga‐AJ206 for CD38 in NSG mice with MM tumor xenografts. A) Whole‐body PET/CT images of different human MM xenografts at 60 min after the injection of radiotracer. Mice were injected with ≈ 7.4 MBq (≈200 µCi) [ 68 Ga]Ga‐AJ206. B) IHC staining for CD38 expression in MM xenografts. C) [ 68 Ga]Ga‐AJ206 uptake quantification (%ID g −1 ) in different MM tumors by ex vivo biodistribution at 60 min after injection. D) PET/CT images of MM1S tumor xenograft‐bearing mice with [ 68 Ga]Ga‐AJ206, with and without pre‐administration of a blocking dose (2 mg kg −1 of AJ206) (tumor denoted with dashed red line). E) [ 68 Ga]Ga‐AJ206 quantification in tumors by ex vivo biodistribution in mice treated with and without a blocking dose; data in figure C and E are shown as box and whisker plots showing all data points ( n = 4–5). Ordinary one‐way ANOVA using multiple comparison test in C and multiple unpaired t test in E. ns, P ≥ 0.05; *, P ≤ 0.05; ** P ≤ 0.01; ***, P ≤ 0.001.

Article Snippet: The ligands used were His‐Tagged human CD38 (R&D systems, catalog # 2404‐AC, 43 kDa, 0.5 mg mL −1 stock concentration) and mouse CD38 proteins (R&D systems, catalog # 4947‐AC, 40 kDa, 1.81 mg mL −1 stock concentration), which were immobilized onto the CM5 chip.

Techniques: In Vivo, Positron Emission Tomography-Computed Tomography, Injection, Immunohistochemistry, Expressing, Ex Vivo, Blocking Assay, Whisker Assay, Comparison

Journal: Advanced Science

Article Title: CD38‐Specific Gallium‐68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET

doi: 10.1002/advs.202308617

Figure Lengend Snippet: Validation of [ 68 Ga]Ga‐AJ206 specificity for CD38 in disseminated MM disease models and primary plasma cell leukemia xenografts. A) IVIS‐bioluminescence image of luciferase expressing MM1S disseminated tumor model. B) In vivo uptake of [ 68 Ga]Ga‐AJ206 in lungs and bones in MM1S‐Luc bearing mice. C) Flow cytometry analysis of CD38 expression in lungs harvested from MM1s‐Luc cells injected mice. Lungs from PBS treated mice were used as controls (top panel). IHC staining of bones shows CD38 expression (bottom panel). D) Rendered in vivo and ex vivo [ 68 Ga]Ga‐AJ206‐PET images of lower limbs of MOLP8 injected animals. E) IHC images of MOLP8 bone marrow tumor and PBS‐treated animals confirmed CD38 expression. F) Quantification of PET signal (%ID/cc) in the bone marrow of PBS, MM1S‐Luc and MOLP8 injected animals. G) Tumor/muscle (T/M) ratios of PET measures in the bone marrow of PBS, MM1S and MOLP8 injected animals. H) Flow cytometry analysis of CD38 expression in cells extracted from the bone marrow of PBS, MM1S‐Luc and MOLP8 cell injected mice. Data in figure F and G are shown as box and whisker plots showing all data points ( n = 7 in PBS, n = 5 in MM1S and n = 8 in MOLP8). Ordinary one‐way ANOVA using multiple comparison test. **, P ≤ 0.01; *** P ≤ 0.001; ****, P ≤ 0.0001.

Article Snippet: The ligands used were His‐Tagged human CD38 (R&D systems, catalog # 2404‐AC, 43 kDa, 0.5 mg mL −1 stock concentration) and mouse CD38 proteins (R&D systems, catalog # 4947‐AC, 40 kDa, 1.81 mg mL −1 stock concentration), which were immobilized onto the CM5 chip.

Techniques: Biomarker Discovery, Clinical Proteomics, Luciferase, Expressing, In Vivo, Flow Cytometry, Injection, Immunohistochemistry, Ex Vivo, Whisker Assay, Comparison

Journal: Advanced Science

Article Title: CD38‐Specific Gallium‐68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET

doi: 10.1002/advs.202308617

Figure Lengend Snippet: Validation of [ 68 Ga]Ga‐AJ206 specificity for CD38 in primary plasma cell leukemia xenografts. A) Flow cytometry histograms of CD38 expression in primary cells. PDX‐1 is from the peripheral blood of a relapsed/refractory MM patient with secondary plasma cell leukemia and PDX‐2 is from a newly diagnosed MM patient bone marrow. Neither had exposure to anti‐CD38 therapies. B) Static whole‐body PET/CT images of PDX bearing mice at 60 min postinjection of [ 68 Ga]Ga‐AJ206. (tumor in dashed red lines) C) IHC analysis of CD38 expression in PDXs.

Article Snippet: The ligands used were His‐Tagged human CD38 (R&D systems, catalog # 2404‐AC, 43 kDa, 0.5 mg mL −1 stock concentration) and mouse CD38 proteins (R&D systems, catalog # 4947‐AC, 40 kDa, 1.81 mg mL −1 stock concentration), which were immobilized onto the CM5 chip.

Techniques: Biomarker Discovery, Clinical Proteomics, Flow Cytometry, Expressing, Positron Emission Tomography-Computed Tomography

Journal: Advanced Science

Article Title: CD38‐Specific Gallium‐68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET

doi: 10.1002/advs.202308617

Figure Lengend Snippet: In vitro and in vivo detection of ATRA treatment induced changes in CD38 expression by [ 68 Ga]Ga‐AJ206 PET in MM cells and PDXs. A) Flow cytometry analysis of ATRA induced changes in surface expression of CD38 in MM cells. B) In vitro uptake of [ 68 Ga]Ga‐AJ206 (%IA) in MM cells treated with ATRA or vehicle control. Cells were incubated with [ 68 Ga]Ga‐AJ206 at 4 °C for 1 h. C) Static whole‐body PET/CT images of PDX bearing NSG mice before and after treatment with ATRA. Red circles indicate tumor. D) Quantification of PET signal in tumors pre‐ and post‐treatment with ATRA. E) Ratio of PET signal in tumors before ( U 0 ) and after ATRA ( U t ) treatment. F) Tumor/muscle ratio of PET measures before and after ATRA treatment G) CD38 IHC of PDXs of untreated and post‐ATRA treated mice; data in figures A and B are represented as mean ± SD ( n = 3 or 4) and significance was calculated by multiple unpaired t test; data in figure D–F are shown for individual mice and significance was calculated using paired t test . ns, P ≥ 0.05; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001.

Article Snippet: The ligands used were His‐Tagged human CD38 (R&D systems, catalog # 2404‐AC, 43 kDa, 0.5 mg mL −1 stock concentration) and mouse CD38 proteins (R&D systems, catalog # 4947‐AC, 40 kDa, 1.81 mg mL −1 stock concentration), which were immobilized onto the CM5 chip.

Techniques: In Vitro, In Vivo, Expressing, Flow Cytometry, Control, Incubation, Positron Emission Tomography-Computed Tomography

Journal: Advanced Science

Article Title: CD38‐Specific Gallium‐68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET

doi: 10.1002/advs.202308617

Figure Lengend Snippet: Parameters of affinity measurements of AJ206 by SPR.

Article Snippet: The ligands used were His‐Tagged human CD38 (R&D systems, catalog # 2404‐AC, 43 kDa, 0.5 mg mL −1 stock concentration) and mouse CD38 proteins (R&D systems, catalog # 4947‐AC, 40 kDa, 1.81 mg mL −1 stock concentration), which were immobilized onto the CM5 chip.

Techniques: Ligand Binding Assay